Charming Medical Limited Class A Ordinary Shares
NASDAQ:MCTAMedical - Care Facilities
+$0.00 today
- Market cap
- $445.55M
- Beta
- 0.00
- P/E (TTM)
- 414.6
- EPS (TTM)
- $0.07
Volume 0.00M
Average 0.87M
MCTA Retained Earnings
Cumulative profits kept in the business rather than paid out as dividends.
Charming Medical Limited Class A Ordinary SharesNASDAQ: MCTA
Retained Earnings · Q4 FY2024 · quarter ended Mar 2025
Retained earnings turns positive
Q4 FY2024 retained earnings was $119.44K, compared with -$1.08M a year earlier.
Context
- Retained earnings amounted to 2.2% of total assets at the end of Q4 FY2024, down 19.9 pp from a year earlier.
- Retained earnings increased in 2 of the last 2 fiscal years.
- FY2024 was the highest annual figure in the 3 fiscal years shown.
What to watch
Whether retained earnings keeps rising in the next quarterly balance sheet after a +111.1% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Retained Earnings history
USD · from the balance sheet
- Latest · FY2024
- 119.44K USD
- Year-over-year change
- +111.1%
| Period | Period end | Retained Earnings | YoY change |
|---|---|---|---|
| FY2024 | 2025-03-31 | 119.44K | +111.1% |
| FY2023 | 2024-03-31 | (1.08M) | +7.1% |
| FY2022 | 2023-03-31 | (1.16M) | — |
Retained Earnings vs competitors
How MCTA compares with its peers on the latest reported figures
- MCTA's Mar 2025 retained earnings of $119.44K is the 3rd highest of the 10 companies compared; the peer median is -$298.78M.
- Its year-over-year change of +111.1% is the highest of 10, against a peer median of -22.5%.
- Retained earnings amounts to 2.2% of total assets for MCTA, versus a peer median of 128.2%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $118.94M | -45.3% | -9.4% | 26.4% | |
| Mar 2026 | $53.18M | +61.7% | — | 19.5% | |
MCTACharming Medical Limited Class A Ordinary Shares | Mar 2025 | $119.44K | +111.1% | — | 2.2% |
| Feb 2026 | -$29.15M | -186.7% | — | 19.9% | |
| Mar 2026 | -$273.91M | -18.9% | — | 162.8% | |
| Mar 2026 | -$298.78M | -3290.0% | — | 48.1% | |
| Mar 2026 | -$529.92M | +0.1% | — | 424.5% | |
| Mar 2026 | -$676.92M | -7.4% | — | 222.7% | |
| Mar 2026 | -$961.53M | -25.7% | — | 365.8% | |
| Mar 2026 | -$1.93B | -22.5% | — | 128.2% | |
| Peer median (excluding MCTA) | -$298.78M | -22.5% | -9.4% | 128.2% | |
Competitors are the stored peer set for MCTA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Charming Medical Limited Class A Ordinary Shares
NASDAQ:MCTA
Intrinsic Alpha fair value
Locked
Current Price
$29.36
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.